Related Experiment Video

Updated: Apr 11, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.6K

Association of seven thrombotic pathway gene CpG-SNPs with coronary heart disease

Huadan Ye1, Annan Zhou1, Qingxiao Hong1

  • 1Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|June 10, 2015
PubMed

Insights

This study found that specific gene variations in CYP2C19 and F7 are linked to coronary heart disease (CHD) risk in the Han Chinese population. These findings highlight potential genetic markers for identifying individuals susceptible to CHD.

Area of Science:

  • Cardiovascular Genetics
  • Thrombotic Pathway Research
  • Human Population Genomics

Background:

  • Coronary heart disease (CHD) is increasingly recognized as a thromboembolic arterial disease.
  • Genetic factors influencing thrombotic pathways are crucial in understanding CHD pathogenesis.
  • Investigating single nucleotide polymorphisms (SNPs) in thrombotic genes offers insights into disease susceptibility.

Purpose of the Study:

  • To investigate the association between CpG-SNPs in thrombotic pathway genes and the risk of coronary heart disease (CHD).
  • To identify specific genetic variations that may contribute to CHD development in the Han Chinese population.

Main Methods:

  • A case-control study involving 784 CHD patients and 738 healthy controls.
  • Genotyping of 7 CpG-SNPs in thrombotic pathway genes (THBS4, CYP2C19, P2RY12, ITGA2, FGB, F7, F5) using Sequenom Mass Spectrometry.
  • Statistical analysis to evaluate SNP associations with CHD risk.

Main Results:

  • CYP2C19 rs12773342 polymorphism showed a significant association with CHD in a recessive model, particularly in individuals aged 55-65.
  • F7 rs510317 polymorphism was significantly associated with CHD risk in males.
  • No significant associations were found for the other investigated CpG-SNPs.

Conclusions:

  • The CYP2C19 rs12773342 and F7 rs510317 polymorphisms are associated with an increased risk of coronary heart disease (CHD).
  • These genetic variations may serve as potential biomarkers for CHD risk assessment in the Han Chinese population.
Abstract

Keywords:
Coronary heart diseaseCpG-SNPPolymorphismPromoterThrombosis

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

5.4K

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
122
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.0K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.3K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
110